Amsale Cherie, Ato Hussen Mekonen, Tsehay Shimelse
1
and C. Hoffmann
1
and O. Bowden-Jones
1
Atun, R.
1
B.S. Kamps
1
Baraldi, E.
1
Bateman, E.D.
1
Begum, T. S. M.
1
Bennett, James et al.
1
BioMed Central
1
BMC
1
BMC Infectious Diseases
1
BMC Medical Education
1
BMC Public Health
1
BMJ Open
1
Bousquet, J.
1
Bozorgmehr, K.
1
Brady, O. J. et all.
1
Braitstein, Paula et al.
1
Brand, P.L. et al.
1
Brozek, J. L.
1
Bush, A.
1
Busse R, Blümel M
1
C. Kouambeng, R. Wounang et. al.
1
C. Beecroft
1
C. Wilcox, L. Lebreton et al.
1
Carrillo-Larco
1
Center for Operational Analysis and Research COAR
1
Centro de Coordinación de Alertasy Emergencias Sanitarias
1
Chen Shen, Nan Xia, et al.
1
Chung, K. F.
1
Cilliers, J.
1
Colley, D.G.
1
Conteh, L. et al.
1
Cook, R.
1
Cucunubá, Z.
1
D. Low-Beer
1
D.M. Bowley, et al.
1
David P.M., Le Dévédec N. et al.
1
Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI) e.V.
1
Development Initiatives Poverty Research Ltd.
1
E. Chiappini
1
E. Venturini
1
Eaton, Jeffrey W.
1
Economist Impact
1
Elaine Abrams, Tsitsi Apollo, Janet Bhila et al.
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Respiratory Journal
1
European Respiratory Journal (ERJ)
1
European Resuscitation Council
1
European specialist nurse organisation (ESN)
1
F. Terris-Prestholt
1
Feiterna- Sperling, C., F. Brinkmann, C. Adamzik, et al.
1
Feng,S.
1
Ference, B.A.
1
FHI 360
1
Fitzgerald, D. A.
1
Fitzgerald, D.A. et al.
1
Freeman, M.C.
1
Future Learn
1
G. B Kulkarni
1
G. Gururaj
1
G. N. Rao
1
G.H. Wills, E. Wobudeya, et al.
1
G4Alliance for surgery, obstetric, trauma and anesthesia care
1
Garratt, A.
1
GBD 2019 Blindness and Vision Impairment Collaborator
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
GBD 2019 Tuberculosis Collaborators
1
GBD2019 Dementia Forecasting Coolaborators
1
Global Initiative for Asthma
1
Global Institute for Asthma
1
Global Nutrition Report Stakeholder Group
1
GP clinics
1
Guo, J.
1
Guzman-Vilca, W. C.
1
H, Getahun
1
H. Getahun
1
H. Kuper and K. Blanchett , et al.
1
H.d Sobel
1
Haddad L., Verburg G., Fore H., et al.
1
Haitham Shoman, Emilie Karafillakis and Salman Rawaf
1
Hanne M. Norseth1,2, Patricia D. Ndhlovu3, Elisabeth Kleppa, et al.
1
Haute Conseil de la Santé Publique
1
Heleen van Beekhuizen and Regine Unkels
1
Helliwell, John F., Richard Layard, Jeffrey Sachs, and Jan-Emmanuel De Neve
1
Hepatology Society of the Philippines (HSP)
1
Hill, A.
1
Hoffmann, C.
1
i-base
1
Imperial Collage London
1
Imperial College COVID-19 Response Team
1
Informe de la Nutrición Mundial
1
Institute for Public Policy Research
1
Institute for Security Studies ISS
1
InterAction, The Rockefeller Foundation
1
International I nitiativ e for Impact E valuation (3ie)
1
International Organization for Migration
1
International Organization for Migration IOM
1
IOP Science
1
J. Atkinson, Y. Chartier, C.L.Pessoa-Silva, et.al
1
J. Dee
1
J. M. Garcia Calleja
1
J. W. Eaton
1
J. Wasserheit, H. Schünemann, et cl.
1
J. Woodring
1
Jacobson, J. et al
1
Journal of Cystic Fibrosis
1
Journal of global health
1
Justin Cohen, Deepika Kandula, Bruno Moonen et al.
1
K. Hauck
1
Kamps, B.S.
1
Kiley, J.
1
Kirakoya-Samadoulougou F., K. Jean, M. Maheu-Giroux
1
L. Newman
1
L.E. Escobar, R. Lowe et al.
1
Lancet Migration
1
Lawrence, E.
1
Lenney, W.
1
Leon-Velarde, F.
1
Liese B
1
M.W. Robinson
1
Madhukar Pai
1
Malaria Journal
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Maternal & Childhealth Advocacy International (MCAI) , Advanced Life Support Group (ALSG)
1
Matthew Hodes and Susan Gau
1
Ministerio de Salud, Peru
1
Ministerio de sanidad - España
1
Ministry of Health, Kenya
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Murray, C.A.
1
N. Ford
1
N. O'Brien, K. Flott, et al.
1
National Agency for the Control of AIDS (NACA)
1
National Clinical Guideline Centre
1
National HIV
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National Tuberculosis Leprosy and Lung Disease Program (NTLD-program), Ministry of Health, Republic of Kenya
1
Nature Communications
1
Naumann, D.N.
1
Ncube, M.
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Nikolaos Mastellos, Tammy Tran, Kanika Dharmayat et al.
1
Norwegian Refugee Council
1
Nouvellet, P.
1
Novel Psychoactive Treatment UK Network (NEPTUNE)
1
OECD
1
Ogden Stephanie et al
1
Ogden, S.
1
Ogden, S., Gallo, K., Davis, S., et al
1
Ojji, D.B.
1
Olivia Fiertag, Sharon Taylor, Amina Tareen & Elena Garralda
1
Olivia Tiberi
1
Olney, Jack J.
1
ONUSIDA
1
OPAS
1
OPAS, IFRC, GOARN, Unicef
1
OPS
1
Organisation Mondiale de la Santé (TB/HIV Working Group)
1
Organisation Mondiale de la Santé OMS
1
Organización Mundial de la Salud (Americas)
1
Organización Panamericana de la Salud
1
O’Neill, J.
1
P. J. Dodd
1
Pan American Health Organisation PAHO
1
Pan American Health Organization (PAHO), OPS
1
Patricia J. Rogers, RMIT University (Australia) and BetterEvaluation
1
Paul Roddy, Natasha Howard, Maria D. Van Kerkhove, et al.
1
Peter Howitt, Ara Darzi, Guang-Zhong Yang, et al.
1
Pijnenburg, M.W.
1
PLOS Medicine
1
PLoS Neglected Tropical Diseases
1
Pollack L. A., D. Plachouras, H. Gruhler et al.
1
PubMed.gov
1
Quirk, E.J.
1
R. Coker
1
R. Thompson, G. Fontana, et al.
1
R.M.
1
Radcliffe
1
Ray, K.K.
1
Review on Antimicrobial Resistance
1
Robert-Koch-Institut RKI
1
Roberton, T.
1
Rutstein, S.E., J. Ananworanich, S. Fidler, et al.
1
S. Aleyan
1
S. Jain
1
S. Ripoll and S. Carter
1
S.Taylor
1
Santesso, N.
1
School Health Integrated Programming (SHIP)
1
Schubert L.
1
Science Direct
1
Séverin, T. et al.
1
Shaw, A.
1
Sightsavers, Department for International Development, The International Trachoma Initiative , et al.
1
Silva, S.
1
Slama, S.
1
Stephen N. Wong, Jane R. Campos, Ian Homer Y. Cua et al.
1
Stevens, Gretchen
1
Stop TB
1
Sustainable Development Solutions Network
1
Szefler, S. J.
1
Tabitha Hrynick, T.
1
The Global Library of Women’s Medicine by Sapiens Publishing
1
The Imperial College
1
The Journal of Global Health
1
The Journal of Headache and Pain
1
The Lancet Commission
1
The Lancet Regional Health - Americas
1
The Montpellier Panel
1
The Republic of Montenegro
1
Transatlantic Taskforce on Antimicrobial Resistance (TATFAR)
1
Turkova, A.
1
UCL Institute for Global Health and Development Education Research Centre, Institute of Education
1
UN Children's Fund UNICEF
1
UN Environment Programme
1
UNFPA
1
UNICEF
1
V. Cambiano
1
V. Habiyambere
1
V.Lemmi
1
VA.Saint, and P. Tinnemann
1
Van de Voorde, P.
1
van Sebille, E.
1
Vassall, A.
1
Walker, N.F.
1
Wenzel, S. E.
1
WHO, UNICEF, UNFPA, World Bank Group and the United Nations Population Division
1
Willott C et al.
1
Word Health Organization
1
World Bank et al.
1
World Business Council for Sustainable Development (WBCSD)
1
World Health Organization (TB/HIV Working Group)
1
World Health Organization (Western Pacific Region)
1
World Health Organization (WHO), Regional Office for South-East-Asia
1
World Health Organization (WHO)
1
World Health Organization Europe
1
World Health Organization WHO, Regional Office for Europe
1
World Health Organization WHO, Regional Office of Europe
1
World Health Organization, Imperial College London
1
World Health Organization, Sout-Easr Asia
1
Worldometer
1
Y. Takashima
1
ВОЗ
1
Всемирная Организация Здравоохранения - Европейское региональное бюро
1
Всемирная организация здравоохранения. Европейское региональное бюро
1
европейская федерация головной боли, всемирная организация здравоохранения, всемирный альянс головной боли et a.
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September.... The FAO panel of experts had met in preparatory sessions from 8 to 12 September. The Meeting was held in pursuance of recommendations made by previous Meetings and accepted by the governing bodies of FAO and WHO that studies should be undertaken jointly by experts to evaluate possible hazards to humans arising from the occurrence of pesticide residues in foods. During the meeting the FAO Panel of Experts was responsible for reviewing pesticide use patterns (use of good agricultural practices), data on the chemistry and composition of the pesticides and methods of analysis for pesticide residues and for estimating the maximum residue levels that might occur as a result of the use of the pesticides according to good agricultural use practices. The WHO Core Assessment Group was responsible for reviewing toxicological and related data and for estimating, where possible and appropriate, acceptable daily intakes (ADIs) and acute reference doses (ARfDs) of the pesticides for humans. This report contains information on ADIs, ARfDs, maximum residue levels, and general principles for the evaluation of pesticides. The recommendations of the Joint Meeting, including further research and information, are proposed for use by Member governments of the respective agencies and other interested parties.more
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...ng the use of non-invasive tests and genotype testing; criteria for offering antiviral treatment; the efficacy, safety and cost effectiveness of currently available treatments; selection of first-line therapy; management of treatment failure or drug resistance; prophylactic treatment during im-
munosuppressive therapy; and monitoring for treatment responsemore
The WHO Global Tuberculosis Report 2022 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
The 2022 edition of the report is as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2022, 202 countries and territories with more than 99% of the world’s population and TB cases reported datamore
The far-reaching impacts of the COVID-19 pandemic underscore the critical need for evidence-informed, transparent and inclusive decision-making. Policy-makers have grappled with complex choices amidst uncertainty. They have constantly reassessed response measures while navigating their economic impl...ications and unintended consequences on societal well-being. Effective communication of the basis for these decisions has also posed a challenge, requiring transparency and public trust.more
On 9 February 2021, a first webinar entitled “Expanding our understanding of Post COVID-19 condition” was held under the auspices of WHO and in consultation with the International Severe Acute Respiratory and Emerging Infection Consortium(ISARIC), Global Research Collaboration for Infectious Dis...ease Preparedness (GloPID-R), National Institutes of Health/National Institute of Allergy and Infectious Diseases(NIH/NIAID), Long Covid SOS and patient representatives.more
This document highlights landmarks and key milestones in the development and implementation of the global agenda for noncommunicable diseases (NCDs) over the last two decades. It summarizes where the world was in 2000, where it is in 2022, and where the world wants to be in terms of NCD prevention a...nd control by 2030. It recalls the commitments made by heads of state and governments, and outlines the technical guidance provided by the World Health Organization (WHO) in support of national efforts to achieve the internationally agreed NCD targets for 2025 and 2030.more
El 31 de diciembrede 2019 las Autoridades de la República Popular China, comunicaron a la OMS varios casos de neumonía de etiología desconocida en Wuhan, una ciudad situada en la provincia china de Hubei. Una semana más tarde confirmaron que se trataba de un nuevo co...ronavirus que ha sido denominado SARS-CoV-2. Al igual que otros de la familia de los coronavirus, este virus causa diversas manifestaciones clínicas englobadas bajoel término COVID-19, que incluyen cuadros respiratorios que varían desde el resfriado común hastacuadros de neumonía grave con síndrome de distrés respiratorio, shock séptico y fallo multi-orgánico. La mayoría de los casos de COVID-19 notificados hasta el momento debutan con cuadros leves.Un punto de detección importante de casos de COVID-19es la urgencia hospitalaria. El triaje tiene como objetivo identificar y priorizar al paciente más grave. Al tratarse deuna enfermedad transmisiblese debenextremar las medidas deprecaución.more
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...nded eligibility for antiviral prophylaxis for pregnant women to prevent mother-to-child transmission of HBV; improving HBV diagnostics through use of point-of-care HBV DNA viral load and reflex approaches to HBV DNA testing; who to test and how to test for HDV infection; and approaches to promote delivery of high-quality HBV services, including strategies to promote adherence to long-term antiviral therapy and retention in care.
The 2024 guidelines include 11 updated chapters with new recommendations and also update existing chapters without new recommendations, such as those on treatment monitoring and surveillance for liver cancer.more
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
20 April 2022. The response to the COVID-19 pandemic continues to adversely affect essential TB services in many countries. A first report of case studies was published in 2021 comprising 23 examples of innovative interventions implemented by countries to effectively respond to disruptions of TB ser...vices caused or exacerbated by the COVID-19 pandemic. This second, consolidated report incorporates new case studies, as well as updates to previously reported case studiesmore
En estas directrices se actualiza la sección de recomendaciones sobre la prevención de la transmisión maternoinfantil de las Directrices para la prevención, la atención y el tratamiento de la infección crónica por el virus de la hepatitis B, publicadas por la OMS en el 2015, y se centra la at...ención en el uso de la profilaxis con antivirales en el embarazo. Su finalidad es proporcionar orientación respaldada por la evidencia acerca del uso de la profilaxis con antivirales durante el periparto en embarazadas que han dado positivo al HBsAg a efectos de prevenir la transmisión maternoinfantil del VHB. Los principales destinatarios son los funcionarios de los ministerios de salud que formulan las políticas nacionales y las directrices sobre la prevención de la transmisión maternoinfantil del VHB en todos los países, pero sobre todo en los de ingresos bajos y medianos. Asimismo, podrías ser útiles para los miembros del personal de salud que tratan a las personas con la infección por el VHB, así como a los que prestan atención a las embarazadas y los lactantes.more
The Strategy to respond to antimalarial drug resistance in Africa is a technical and advocacy document, grounded in the best available evidence to date and aimed at minimizing the threat and impact of antimalarial drug resistance of Plasmodium falciparum parasites in Africa. Its objectives are to: i...) improve the detection of resistance to ensure a timely response; ii) delay the emergence of resistance to artemisinin and artemisinin-based combination therapy (ACT) partner drugs; and iii) limit the selection and spread of resistant parasites where resistance has been confirmed.
WHO Team
Global Malaria Programme
Editors
World Health Organization
Number of pages
87
Reference numbers
ISBN: 978 92 4 006026 5
Copyrightmore
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...sure to infection is crucial for assessing progress and for understanding the priorities to achieve these milestones.more
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A... neglected tropical disease (NTD) list in 2013, snakebite envenoming was reinstated in 2017 in response to antivenom shortages and advocacy from researchers and international NGOs. In 2019, the World Health Organization (WHO) set a target to halve the number of deaths and cases of snakebite envenoming by 2030.more